EVE A TABLETS EX (40 tablets)

【Product Description】
An antipyretic-analgesic OTC medicine. Each dose (2 tablets) contains ibuprofen 200 mg, with allylisopropylacetylurea and anhydrous caffeine to enhance the analgesic effect.

⸻

【Indications】
Relief of pain: menstrual pain, headache / shoulder stiffness pain, sore throat, joint pain, muscle pain, nerve pain, lower back pain, pain after tooth extraction, contusion pain, ear pain, fracture pain, sprain pain, traumatic pain.
Relief of chills and fever.

⸻

【Dosage and Administration】
Adults (15 years or older): 2 tablets per dose, up to 2 times daily.
Children under 15 years: Do not take.
Take with cold or lukewarm water. Avoid taking on an empty stomach when possible. Keep at least 6 hours between doses.

⸻

【Active Ingredients (per dose: 2 tablets)】
Ibuprofen 200 mg
Allylisopropylacetylurea 60 mg
Anhydrous caffeine 80 mg

⸻

【Contraindications (excerpt)】
Do not take if:
- You have had an allergic reaction to any ingredient of this product.
- You have experienced asthma after taking this product or other antipyretic-analgesics / common cold medicines.
- You are under 15 years of age.
- You are pregnant with a due date within 12 weeks.

While taking this product, do not take: other antipyretic-analgesics, common cold medicines, sedatives, or motion sickness medicines.
Do not operate vehicles or machinery after taking (sleepiness may occur).
Do not take soon before or soon after alcohol intake.
Do not use for a long and continuing period.

⸻

【Consultation (key points)】
Consult a physician/dentist/pharmacist/registered salesperson before taking if you are receiving treatment, are or may be pregnant, are breastfeeding, are elderly, have a history of allergies, have been diagnosed with heart/kidney/liver disease, SLE, or MCTD, or have a history of gastroduodenal ulcer, ulcerative colitis, or Crohn’s disease.
Stop taking and consult if side effects occur.
If there is no alleviation after 3 or 4 doses, stop taking and consult.

⸻

Source: Manufacturer’s package insert (Revised October 2024)